Leaderboard (728 x 90) ad space available.

The Finance

singaporeanstocksinvestor.blogspot.sg Webutation

Singapore Business

Business News

The Edge Singapore

Gold and Silver

Recent Comments

Archives


Healthway Medical: 3Q 2010 results.

Saturday, November 13, 2010

Healthway Medical's results came in rather weak, as expected:

1.  Revenue declined 6.2% in Q3 compared to the same period last year.  For the first 9 months, revenue declined 8.3% compared to the same period last year.

2. Staff cost increased 19.2% in Q3 compared to the same period last year.

3. Profit before income tax decreased 87.3% to $568k in Q3 compared to the same period last year.

4. Cash flow from operations is negative for the quarter at -$1.278m.

5. EPS for the quarter is 0.01c, remaining the same as the last quarter but down from 0.29c in the same quarter last year.

See results here.

We are still in the tunnel but do we see a tiny glow at the end of the tunnel?

A. Although revenue declined 6.2% compared to the same period last year, this is a smaller decline compared to Q2's decline of 12.3%. 

B. Staff cost increase of 19.2% is also smaller than Q2's 22.9%. 

C. Profit before income tax in Q2 was only $165k. So, Q3's $568k is an improvement. 

D. Cash flow from operations in Q2 was a negative $2.3m compared to a smaller negative $1.278m in Q3. 

Perhaps, points C and D are the most important indicators that things could be stabilising. However, it is still too early to say for sure.

Having said this, the proposed diversification could throw a spanner in the works. One could only hope that Healthway Medical is not biting off more than it could chew.

On 25 Oct, I suggested that Healthway Medical's share price could have found a floor at 15c. I also mentioned that any rebound would be a good chance for stale bulls to reduce exposure. 17c was never hit as the rebound in price went as high as 16.5c before declining again.


The last session saw Healthway Medical closing at 15.5c. With the MACD, MFI and RSI all in their respective downtrends, a retest of the support at 15c is rather likely. Consolation? Volume has been declining in the last few sessions. So, we could have a soft landing.

Related posts:
Healthway Medical: Second quarter results.
Healthway Medical: Business diversification.
Healthway Medical: A floor at 15c?

Rickmers Maritime: DPU in Q3 down 5%.

Mainboard-listed Rickmers Maritime said the dip is because of lower charter revenue from containership Kaethe C. Rickmers, as well as an increase in interest costs.

Read article here


Rickmers Maritime Trust says it will distribute 0.57 US cents (0.74 cents) per unit to unitholders for the third quarter and nine months ended 30 September 2010 (3Q2010), the same DPU as in 2Q2010.

The declared distribution, representing a payout of 13% of income available for distribution, will be paid to unitholders on 15 December 2010.


CapitaMalls Asia: Uptrend broken.

Connecting the lows of 7 May and 25 Aug gives us the uptrend support line of CapitaMalls Asia.  This support was retested on 8 Nov.  Price bounced off and went higher for a couple of days only to decline again. In the last session, the counter traded the whole day below this support line. The uptrend is broken.


The 20dMA, after completing a dead cross with the 50dMA, seems set to form another dead cross with the flat 100dMA.  The longer term 200dMA is still descending.

The MACD has formed a lower high in negative territory as it turned down away from the signal line.  Momentum is negative. MFI and RSI have both formed lower highs, suggesting a lack of demand and buying momentum. The OBV suggests continual distribution. All technicals confirm that the downward trajectory in price has some strength.

In the event of a continuing downward movement in price, stronger supports are at $2.04 and $2.00 thereabouts. Immediate resistance at $2.12.

 
 
Bloggy Award